Clinical trial
Efficacy and Safety of Decitabine in Combination With Low-dose Cytarabine as Inductive Treatment in Newly Diagnosed Elderly Patients With Acute Myeloid Leukemia
NCT02985372 is registered in ClinicalTrials.gov with Chunyan Ji as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Decitabine in Combination With Low-dose Cytarabine as Inductive Treatment in Newly Diagnosed Elderly Patients With Acute Myeloid Leukemia
- Lead sponsor
- Chunyan Ji
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2016
- Completion date
- December 31, 2019
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia, adult